New framework for measuring the impact of life sciences patents highlights the growing importance of academia in accelerating biomedical innovation
MIT researchers develop methodology for systematically tracking the outcomes of academic licensing transactions as a means of increasing funding to bridging the valley of death.
News provided by
Share this article
Share this article
CAMBRIDGE, Mass., March 11, 2021 /PRNewswire/ Despite a surge in recent years in the number of biotech startup companies spinning out of academia, little data has been collected on the impact of academic technology transfer. In an article published in
Nature Biotechnology, MIT researchers address this gap by developing a framework for tracking innovation in the life sciences sector with origins in academia.